Cytokinetics, Incorporated
US ˙ NasdaqGS ˙ US23282W6057

SecurityCYTK / Cytokinetics, Incorporated
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in CYTK / Cytokinetics, Incorporated

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Cytokinetics, Incorporated (US:CYTK) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 110,260 shares of Cytokinetics, Incorporated. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 0 -110,260 -100.00 0 -100.00
2025-11-13 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 110,260 26,388 31.46 6,060 118.69 0.0071
2025-08-14 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 83,872 9,466 12.72 2,771 -7.32 0.0034
2025-08-14 2025-03-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 74,406 -1,027 -1.36 2,990 -15.73 0.0037
2025-05-15 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 74,406 -1,027 2,990 0.0024
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 75,433 1,533 2.07 3,548 -9.07 0.0043
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 73,900 301 0.41 3,902 -2.16 0.0042
2024-08-09 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 73,599 -27,445 -27.16 3,988 -43.70 0.0046
2024-05-14 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 101,044 59,060 140.67 7,084 102.11 0.0080
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 41,984 -5,775 -12.09 3,505 149.11 0.0040
2023-11-14 2023-09-30 13F CYTOKINETICS COM NEW 23282W605 47,759 9,059 23.41 1,407 11.49 0.0018
2023-10-27 2023-06-30 13F/A-2 CYTOKINETICS COM NEW 23282W605 38,700 2,276 6.25 1,262 -1.56 0.0014
2023-10-12 2023-06-30 13F/A-1 CYTOKINETICS COM NEW 23282W605 38,700 2,276 1,262 0.0013
2023-08-14 2023-06-30 13F CYTOKINETICS COM NEW 23282W605 38,700 2,276 1,262 0.0013
2023-06-01 2023-03-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 36,424 -37,236 -50.55 1,282 -62.01 0.0015
2023-05-15 2023-03-31 13F CYTOKINETICS COM NEW 23282W605 36,424 -37,236 1,282 0.0012
2023-02-21 2022-12-31 13F CYTOKINETICS COM NEW 23282W605 73,660 -40,645 -35.56 3,375 -39.48 0.0040
2022-11-14 2022-09-30 13F CYTOKINETICS COM NEW 23282W605 114,305 34,847 43.86 5,577 78.64 0.0068
2022-08-17 2022-06-30 13F/A-1 CYTOKINETICS COM NEW 23282W605 79,458 28,156 54.88 3,122 65.36 0.0035
2022-08-15 2022-06-30 13F CYTOKINETICS COM NEW 23282W605 79,458 28,156 3,122 0.0011
2022-05-16 2022-03-31 13F CYTOKINETICS COM NEW 23282W605 51,302 5,655 12.39 1,888 -9.27 0.0014
2022-02-11 2021-12-31 13F Cytokinetics COM NEW 23282W605 45,647 -15,316 -25.12 2,081 -4.50 0.0017
2021-11-12 2021-09-30 13F CYTOKINETICS COM NEW 23282W605 60,963 -13,636 -18.28 2,179 47.63 0.0019
2021-08-13 2021-06-30 13F CYTOKINETICS COM NEW 23282W605 74,599 -160 -0.21 1,476 -15.12 0.0012
2021-05-14 2021-03-31 13F CYTOKINETICS COM NEW 23282W605 74,759 4,469 6.36 1,739 19.03 0.0025
2021-02-16 2020-12-31 13F CYTOKINETICS COM NEW 23282W605 70,290 68,333 3,491.72 1,461 3,378.57 0.0021
2020-11-13 2020-09-30 13F CYTOKINETICS COM NEW 23282W605 1,957 0 0.00 42 -8.70 0.0001
2020-08-11 2020-06-30 13F CYTOKINETICS COM NEW 23282W605 1,957 1,957 46 0.0001
2018-05-11 2018-03-31 13F CYTOKINETICS COM NEW 23282W605 0 -900 -100.00 0 -100.00
2018-02-14 2017-12-31 13F CYTOKINETICS COM NEW 23282W605 900 900 7 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.